Azitra (AZTR) Depreciation and Depletion (2022 - 2026)
Azitra (AZTR) reported Depreciation and Depletion of $33081.0 for Q1 2026, up 6.83% on a YoY basis from $30967.0 in Q1 2025, and up 5.89% quarter-over-quarter from $31240.0 in Q4 2025.
Azitra (AZTR) Depreciation and Depletion (2022 - 2026) Analysis & Trends
Azitra has reported Depreciation and Depletion for 5 years, with the latest figure at $33081.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 6.83% year-over-year to $33081.0; the trailing twelve-month figure through Mar 2026 stood at $126471.0 (up 4.47% YoY), and the FY2025 full-year result was $124357.0, up 3.61% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $33081.0, up from $31240.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $33081.0 in Q1 2026, with the low at $29935.0 in Q1 2024.
- Historically, Depreciation and Depletion has averaged $30644.8 across 5 years, with a median of $30519.0 in 2022.
- Annual changes were most pronounced in 2024 — Depreciation and Depletion dropped 3.05% — and 2026, when it increased 6.83%.
- Azitra's Depreciation and Depletion stood at $30486.0 in 2022, then dropped by 1.56% to $30010.0 in 2023, then gained by 0.46% to $30149.0 in 2024, then climbed by 3.62% to $31240.0 in 2025, then rose by 5.89% to $33081.0 in 2026.
- The last three Depreciation and Depletion figures came in at $33081.0 (Q1 2026), $31240.0 (Q4 2025), and $31041.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 33,081.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,081.00 |
| Mar 31, 2026 | 33,081.00 |
| Dec 31, 2025 | 31,240.00 |
| Dec 31, 2025 | 31,240.00 |
| Sep 30, 2025 | 31,041.00 |
| Sep 30, 2025 | 31,041.00 |
| Jun 30, 2025 | 31,109.00 |
| Jun 30, 2025 | 31,109.00 |
| Mar 31, 2025 | 30,967.00 |
| Mar 31, 2025 | 30,967.00 |
| Dec 31, 2024 | 30,149.00 |
| Dec 31, 2024 | 30,149.00 |
| Sep 30, 2024 | 30,007.00 |
| Sep 30, 2024 | 30,007.00 |
| Jun 30, 2024 | 29,935.00 |
| Jun 30, 2024 | 29,935.00 |
| Mar 31, 2024 | 29,935.00 |
| Mar 31, 2024 | 29,935.00 |
| Dec 31, 2023 | 30,010.00 |
| Dec 31, 2023 | 30,010.00 |